HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2012–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	5	1
2024	—	4	1
2023	—	5	1
2022	—	4	1
2021	—	5	2
2020	—	4	1
2019	—	6	2
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.	—	25
FAEGRE DRINKER BIDDLE & REATH LLP	—	32
POWERS PYLES SUTTER & VERVILLE, P.C.	—	8

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	58
SENATE	57
White House Office	14
Centers For Medicare and Medicaid Services (CMS)	7
Food & Drug Administration (FDA)	7
Health & Human Services, Dept of (HHS)	3
Vice President of the U.S.	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	63
Budget/Appropriations	Budget/Appropriations	52
Medicare/Medicaid	Medicare/Medicaid	22
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	7
Pharmacy	Pharmacy	1
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3514119th Congress

Improving Seniors’ Timely Access to Care Act of 2025

2026 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

Cancer Drug Parity Act (H.R. 4101 / S. 5004); Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816); Drug Shortages

Client expense: — · Firm income: $50,000

Matched citations: H.R. 3514

H.R. 4101119th Congress

Cancer Drug Parity Act of 2025

2026 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

Cancer Drug Parity Act (H.R. 4101 / S. 5004); Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816); Drug Shortages

Client expense: — · Firm income: $50,000

Matched citations: H.R. 4101

S. 1816119th Congress

Improving Seniors’ Timely Access to Care Act of 2025

2026 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

Cancer Drug Parity Act (H.R. 4101 / S. 5004); Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816); Drug Shortages

Client expense: — · Firm income: $50,000

Matched citations: S. 1816

S. 5004119th Congress

Cancer Drug Parity Act of 2026

2026 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

Cancer Drug Parity Act (H.R. 4101 / S. 5004); Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816); Drug Shortages

Client expense: — · Firm income: $50,000

Matched citations: S. 5004

Show 21 more cited filings

H.R. 4101119th Congress

Cancer Drug Parity Act of 2025

2026 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

Safe Step Act (H.R. 5509 / S. 2903); Cancer Drug Parity Act (H.R. 4101)

Client expense: — · Firm income: $50,000

Matched citations: H.R. 4101

H.R. 5509119th Congress

Safe Step Act

2026 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

Safe Step Act (H.R. 5509 / S. 2903); Cancer Drug Parity Act (H.R. 4101)

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5509

S. 2903119th Congress

Safe Step Act

2026 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

Safe Step Act (H.R. 5509 / S. 2903); Cancer Drug Parity Act (H.R. 4101)

Client expense: — · Firm income: $50,000

Matched citations: S. 2903

H.R. 3521119th Congress

Clinical Trial Modernization Act

2025 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 4101, The Cancer Drug Parity Act; HR 3521, the Clinical Trials Moderization Act; Drug Shortages

Client expense: — · Firm income: $50,000

Matched citations: HR 3521

H.R. 4101119th Congress

Cancer Drug Parity Act of 2025

2025 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 4101, The Cancer Drug Parity Act; HR 3521, the Clinical Trials Moderization Act; Drug Shortages

Client expense: — · Firm income: $50,000

Matched citations: HR 4101

H.R. 3521119th Congress

Clinical Trial Modernization Act

2025 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 4101, The Cancer Drug Parity Act; HR 3521, the Clinical Trials Moderization Act; Drug Shortages

Client expense: — · Firm income: $50,000

Matched citations: HR 3521

H.R. 4101119th Congress

Cancer Drug Parity Act of 2025

2025 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

HR 4101, The Cancer Drug Parity Act; HR 3521, the Clinical Trials Moderization Act; Drug Shortages

Client expense: — · Firm income: $50,000

Matched citations: HR 4101

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1770

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2407

H.R. 6301118th Congress

Cancer Drug Parity Act of 2023

2024 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: H.R.6301

S. 1491118th Congress

Pharmacy and Medically Underserved Areas Enhancement Act

2024 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: S. 1491

S. 2039118th Congress

Cancer Drug Parity Act of 2023

2024 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: S.2039

S. 2085118th Congress

Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: S. 2085

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1770

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2407

H.R. 6301118th Congress

Cancer Drug Parity Act of 2023

2024 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: H.R.6301

S. 1491118th Congress

Pharmacy and Medically Underserved Areas Enhancement Act

2024 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: S. 1491

S. 2039118th Congress

Cancer Drug Parity Act of 2023

2024 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: S.2039

S. 2085118th Congress

Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.2039/H.R.6301, the Cancer Drug Parity Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 1770, the Equitable Community Access to Pharmacist Services Act, S. 2085/H.R. 2407, the Medicare Multi-Cancer Early Detection Screening Coverage Act, Cancer Moonshoot

Client expense: — · Firm income: $50,000

Matched citations: S. 2085

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S. 2039, the Cancer Drug Parity Act; S 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, HR 1770, the Equitable Community Access to Pharmacist Services Act; Cancer Moonshot; Drug Shortages

Client expense: — · Firm income: $50,000

Matched citations: HR 1770

S. 1491118th Congress

Pharmacy and Medically Underserved Areas Enhancement Act

2024 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S. 2039, the Cancer Drug Parity Act; S 1491, the Pharmacy and Medically Underserved Areas Enhancement Act, HR 1770, the Equitable Community Access to Pharmacist Services Act; Cancer Moonshot; Drug Shortages

Client expense: — · Firm income: $50,000

Matched citations: S 1491

Source: Senate LDA

HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION — Lobbying Disclosure | Poliscope